These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 10930148)
1. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA. Molina JM; Goguel J; Sarfati C; Michiels JF; Desportes-Livage I; Balkan S; Chastang C; Cotte L; Maslo C; Struxiano A; Derouin F; Decazes JM AIDS; 2000 Jul; 14(10):1341-8. PubMed ID: 10930148 [TBL] [Abstract][Full Text] [Related]
2. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group. Molina JM; Goguel J; Sarfati C; Chastang C; Desportes-Livage I; Michiels JF; Maslo C; Katlama C; Cotte L; Leport C; Raffi F; Derouin F; Modaï J AIDS; 1997 Nov; 11(13):1603-10. PubMed ID: 9365765 [TBL] [Abstract][Full Text] [Related]
3. Fumagillin treatment of intestinal microsporidiosis. Molina JM; Tourneur M; Sarfati C; Chevret S; de Gouvello A; Gobert JG; Balkan S; Derouin F; N Engl J Med; 2002 Jun; 346(25):1963-9. PubMed ID: 12075057 [TBL] [Abstract][Full Text] [Related]
5. Fumagillin for intestinal microsporidiosis. Carr A; Cooper DA N Engl J Med; 2002 Oct; 347(17):1381; author reply 1381. PubMed ID: 12397205 [No Abstract] [Full Text] [Related]
6. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Champion L; Durrbach A; Lang P; Delahousse M; Chauvet C; Sarfati C; Glotz D; Molina JM Am J Transplant; 2010 Aug; 10(8):1925-30. PubMed ID: 20636462 [TBL] [Abstract][Full Text] [Related]
7. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. Dieterich DT; Lew EA; Kotler DP; Poles MA; Orenstein JM J Infect Dis; 1994 Jan; 169(1):178-83. PubMed ID: 8277179 [TBL] [Abstract][Full Text] [Related]
8. Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis. Menotti J; Cassinat B; Porcher R; Sarfati C; Derouin F; Molina JM J Infect Dis; 2003 May; 187(9):1469-74. PubMed ID: 12717629 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study. Maillard A; Scemla A; Laffy B; Mahloul N; Molina JM J Antimicrob Chemother; 2021 Jan; 76(2):487-494. PubMed ID: 33128055 [TBL] [Abstract][Full Text] [Related]
10. Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin. Godron A; Accoceberry I; Couret A; Llanas B; Harambat J Transplantation; 2013 Oct; 96(8):e66-7. PubMed ID: 24132119 [No Abstract] [Full Text] [Related]
11. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review. Lanternier F; Boutboul D; Menotti J; Chandesris MO; Sarfati C; Mamzer Bruneel MF; Calmus Y; Mechaï F; Viard JP; Lecuit M; Bougnoux ME; Lortholary O Transpl Infect Dis; 2009 Feb; 11(1):83-8. PubMed ID: 18803616 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant. Desoubeaux G; Maakaroun-Vermesse Z; Lier C; Bailly E; Morio F; Labarthe F; Bernard L; Chandenier J Transpl Infect Dis; 2013 Dec; 15(6):E250-9. PubMed ID: 24298986 [TBL] [Abstract][Full Text] [Related]
13. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis. Audemard A; Le Bellec ML; Carluer L; Dargère S; Verdon R; Castrale C; Lobbedez T; Hurault de Ligny B Transpl Infect Dis; 2012 Dec; 14(6):E147-9. PubMed ID: 23025483 [TBL] [Abstract][Full Text] [Related]
14. Enterocytozoon bieneusi multiorgan microsporidiosis in a HIV-infected patient. Georges E; Rabaud C; Amiel C; Kurès L; Guedenet JC; Allamagny E; May T; Canton P J Infect; 1998 Mar; 36(2):223-5. PubMed ID: 9570660 [TBL] [Abstract][Full Text] [Related]
15. [Bilateral microsporidial keratitis in an HIV-positive patient with AIDS stage infection]. Kersten A; Althaus C; Seitz HM; Pfahl HG; Sundmacher R Klin Monbl Augenheilkd; 1998 Jun; 212(6):476-9. PubMed ID: 9715470 [TBL] [Abstract][Full Text] [Related]
16. Therapy for human gastrointestinal microsporidiosis. Conteas CN; Berlin OG; Ash LR; Pruthi JS Am J Trop Med Hyg; 2000; 63(3-4):121-7. PubMed ID: 11388502 [TBL] [Abstract][Full Text] [Related]
17. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Didier ES Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637 [TBL] [Abstract][Full Text] [Related]
18. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. Carr A; Marriott D; Field A; Vasak E; Cooper DA Lancet; 1998 Jan; 351(9098):256-61. PubMed ID: 9457096 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model. Feng X; Reddy VK; Mayanja-Kizza H; Weiss LM; Marton LJ; Tzipori S Antimicrob Agents Chemother; 2009 Jun; 53(6):2417-23. PubMed ID: 19289524 [TBL] [Abstract][Full Text] [Related]
20. Intestinal microsporidiosis in India: a two year study. Saigal K; Sharma A; Sehgal R; Sharma P; Malla N; Khurana S Parasitol Int; 2013 Feb; 62(1):53-6. PubMed ID: 23022364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]